Thank you very much.
I think I'm still having trouble with the context of where the national pharmaceutical strategy is. Maybe you could update me, from what the deputy ministers have agreed to.
The EU has a common formulary, and we heard from the five formularies that are in the federal government. Where does the CDR fit, in moving towards a common formulary? And what timeframe are we looking at in terms of generics and the other pieces? I know about the budget and the mandate you have, but where do you, as deputy ministers, see this in the process, and how long will it take for us to actually not have these little bits and be able to get on to an actual national pharmaceutical strategy that includes an approach to expensive drugs for rare diseases, catastrophic drug coverage, and our moving as a country beyond what was there in the Canada Health Act, when everything happened by doctors and in hospitals and drugs weren't as important?